Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph B Margolick

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
AIDS (London, England)|December 4, 2002
Virologic and immunologic values allowing safe deferral of antiretroviral therapyJohn P Phair, John W Mellors, Roger Detels, et al.
Breast Cancer Research and Treatment|May 29, 2008
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse modelJiangbing Zhou, Hao Zhang, Peihua Gu, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Decreased MIP-3α Production from Antigen-Activated PBMCs in Symptomatic HIV-Infected SubjectsFuchun Zhang, Lingling Sun, Mark K Lafferty, et al.
Breast Cancer Research and Treatment|October 30, 2007
NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cellsJiangbing Zhou, Hao Zhang, Peihua Gu, et al.
Lancet (London, England)|September 27, 2003
Anatomical loci of HIV-associated immune activation and association with viraemiaSujatha Iyengar, Bennett Chin, Joseph B Margolick, et al.
Journal of Medical Virology|May 29, 2009
Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patientsMary K Grabowski, Raphael P Viscidi, Joseph B Margolick, et al.
Pharmacotherapy|April 28, 2006
High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infectionBeulah P Sabundayo, Julie H McArthur, Susan J Langan, et al.
The Journal of Antimicrobial Chemotherapy|September 4, 2013
Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cellsLiang Shan, Sifei Xing, Hung-Chih Yang, et al.
American Journal of Epidemiology|August 4, 2005
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell countStephen R Cole, Miguel A Hernán, Joseph B Margolick, et al.
Experimental Gerontology|January 25, 2005
T cell subsets and mortality in older community-dwelling womenRichard D Semba, Joseph B Margolick, Sean Leng, et al.
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
AIDS (London, England)|December 4, 2002
Virologic and immunologic values allowing safe deferral of antiretroviral therapyJohn P Phair, John W Mellors, Roger Detels, et al.
Breast Cancer Research and Treatment|May 29, 2008
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse modelJiangbing Zhou, Hao Zhang, Peihua Gu, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Decreased MIP-3α Production from Antigen-Activated PBMCs in Symptomatic HIV-Infected SubjectsFuchun Zhang, Lingling Sun, Mark K Lafferty, et al.
Breast Cancer Research and Treatment|October 30, 2007
NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cellsJiangbing Zhou, Hao Zhang, Peihua Gu, et al.
Lancet (London, England)|September 27, 2003
Anatomical loci of HIV-associated immune activation and association with viraemiaSujatha Iyengar, Bennett Chin, Joseph B Margolick, et al.
Journal of Medical Virology|May 29, 2009
Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patientsMary K Grabowski, Raphael P Viscidi, Joseph B Margolick, et al.
Pharmacotherapy|April 28, 2006
High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infectionBeulah P Sabundayo, Julie H McArthur, Susan J Langan, et al.
The Journal of Antimicrobial Chemotherapy|September 4, 2013
Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cellsLiang Shan, Sifei Xing, Hung-Chih Yang, et al.
American Journal of Epidemiology|August 4, 2005
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell countStephen R Cole, Miguel A Hernán, Joseph B Margolick, et al.
Experimental Gerontology|January 25, 2005
T cell subsets and mortality in older community-dwelling womenRichard D Semba, Joseph B Margolick, Sean Leng, et al.
Pageof 25